WallStreetZenWallStreetZen

NASDAQ: IRWD
Ironwood Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for IRWD

Based on 3 analysts offering 12 month price targets for Ironwood Pharmaceuticals Inc

Min Forecast
$0.70-34.58%
Avg Forecast
$0.90-15.89%
Max Forecast
$1.00-6.54%

Should I buy or sell IRWD stock?

Based on 3 analysts offering ratings for Ironwood Pharmaceuticals Inc.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
3 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IRWD stock forecasts and price targets.

IRWD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-15
lockedlocked$00.00+00.00%2025-04-15
lockedlocked$00.00+00.00%2025-04-14

1 of 1

Forecast return on equity

Is IRWD forecast to generate an efficient return?

Company
N/A
Industry
31.2%
Market
-46.52%

Forecast return on assets

Is IRWD forecast to generate an efficient return on assets?

Company
-8.53%
Industry
14.69%
IRWD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

IRWD earnings per share forecast

What is IRWD's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.19
Avg 2 year Forecast
$0.39
Avg 3 year Forecast
-$0.03

IRWD revenue forecast

What is IRWD's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$267.3M-13.37%
Avg 2 year Forecast
$252.4M-18.21%
Avg 3 year Forecast
$226.2M-26.68%
IRWD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IRWD revenue growth forecast

How is IRWD forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
-9.48%
Industry
4.31%
Market
10.99%
IRWD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IRWD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IRWD vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
IRWD$1.07$0.90-15.89%Hold
DERM$7.26$12.50+72.18%Strong Buy
BIOA$4.46$5.00+12.11%Sell
OGI$1.56N/AN/A
CTOR$1.72N/AN/A
View Top Pharmaceutical Stocks

Ironwood Pharmaceuticals Stock Forecast FAQ

Is Ironwood Pharmaceuticals Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: IRWD) stock is to Hold IRWD stock.

Out of 3 analysts, 0 (0%) are recommending IRWD as a Strong Buy, 0 (0%) are recommending IRWD as a Buy, 3 (100%) are recommending IRWD as a Hold, 0 (0%) are recommending IRWD as a Sell, and 0 (0%) are recommending IRWD as a Strong Sell.

If you're new to stock investing, here's how to buy Ironwood Pharmaceuticals stock.

What is IRWD's earnings growth forecast for 2025-2027?

(NASDAQ: IRWD) Ironwood Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 23.63%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.25%.

Ironwood Pharmaceuticals's earnings in 2025 is -$7,885,000.On average, 3 Wall Street analysts forecast IRWD's earnings for 2025 to be $30,326,452, with the lowest IRWD earnings forecast at $11,370,389, and the highest IRWD earnings forecast at $43,857,215. On average, 3 Wall Street analysts forecast IRWD's earnings for 2026 to be $63,885,343, with the lowest IRWD earnings forecast at $56,851,946, and the highest IRWD earnings forecast at $69,846,676.

In 2027, IRWD is forecast to generate -$4,873,024 in earnings, with the lowest earnings forecast at -$4,873,024 and the highest earnings forecast at -$4,873,024.

What is IRWD's revenue growth forecast for 2025-2027?

(NASDAQ: IRWD) Ironwood Pharmaceuticals's forecast annual revenue growth rate of -9.48% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.31%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.99%.

Ironwood Pharmaceuticals's revenue in 2025 is $308,519,000.On average, 3 Wall Street analysts forecast IRWD's revenue for 2025 to be $43,412,145,584, with the lowest IRWD revenue forecast at $42,879,361,637, and the highest IRWD revenue forecast at $44,474,464,794. On average, 3 Wall Street analysts forecast IRWD's revenue for 2026 to be $40,990,252,706, with the lowest IRWD revenue forecast at $39,763,875,024, and the highest IRWD revenue forecast at $42,882,610,320.

In 2027, IRWD is forecast to generate $36,745,036,718 in revenue, with the lowest revenue forecast at $36,710,113,380 and the highest revenue forecast at $36,779,960,056.

What is IRWD's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: IRWD) forecast ROA is -8.53%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 14.69%.

What is IRWD's Price Target?

According to 3 Wall Street analysts that have issued a 1 year IRWD price target, the average IRWD price target is $0.90, with the highest IRWD stock price forecast at $1.00 and the lowest IRWD stock price forecast at $0.70.

On average, Wall Street analysts predict that Ironwood Pharmaceuticals's share price could fall to $0.90 by Apr 15, 2026. The average Ironwood Pharmaceuticals stock price prediction forecasts a potential downside of 15.89% from the current IRWD share price of $1.07.

What is IRWD's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: IRWD) Ironwood Pharmaceuticals's current Earnings Per Share (EPS) is -$0.04. On average, analysts forecast that IRWD's EPS will be $0.19 for 2025, with the lowest EPS forecast at $0.07, and the highest EPS forecast at $0.27. On average, analysts forecast that IRWD's EPS will be $0.39 for 2026, with the lowest EPS forecast at $0.35, and the highest EPS forecast at $0.43. In 2027, IRWD's EPS is forecast to hit -$0.03 (min: -$0.03, max: -$0.03).

What is IRWD's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: IRWD) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.